Senores Pharmaceuticals, Inc. announces the launch of Mexiletine Hydrochloride Capsules USP, 150 mg, 200 mg and 250 mg with one of the top generic pharmaceutical companies in the U.S. market
Jan 27, 2022
Atlanta (Georgia) [US], January 27 (ANI/PRNewswire): Senores Pharmaceuticals, Inc. announced the launch of Mexiletine Hydrochloride Capsules USP, 150 mg, 200 mg and 250 mg,...